Related Experiment Video
Updated: May 20, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Outcomes of Multivessel Percutaneous Coronary Intervention in Diabetic and Non-Diabetic Patients
Syed Tahir Shah1, Syed Muzammil Shah1
1Department of Cardiology, Kuwait Teaching Hospital, Peshawar, Pakistan.
Insights
Multivessel percutaneous coronary intervention (PCI) improved angina, ejection fraction (EF), and dyspnoea in both diabetic and non-diabetic patients. However, outcomes were consistently better for non-diabetic individuals, indicating a need for tailored strategies.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Coronary artery disease (CAD) affects millions globally, with diabetes mellitus being a significant risk factor.
- Multivessel CAD requires effective revascularization strategies, such as percutaneous coronary intervention (PCI).
- Assessing the impact of diabetes on PCI outcomes is crucial for patient management.
Purpose of the Study:
- To compare the effectiveness of multivessel PCI in patients with and without diabetes.
- To evaluate improvements in angina, ejection fraction (EF), and dyspnoea post-PCI.
- To identify factors influencing PCI outcomes in diabetic versus non-diabetic patients.
Main Methods:
- An observational study conducted in Peshawar, Pakistan, from January 2020 to December 2022.
- Included 500 patients (250 diabetic, 250 non-diabetic) with multivessel CAD undergoing PCI.
- Assessed CCS angina grade, EF, and NYHA dyspnoea classification at 1, 3, 6, and 12 months post-procedure using statistical analyses including t-tests and regression.
Main Results:
- Diabetic patients presented with more severe disease (higher angina, lower EF) than non-diabetic patients.
- Non-diabetic patients showed significantly greater improvements in angina grade and EF post-PCI.
- Dyspnoea reduction was similar between groups; diabetes independently predicted reduced treatment efficacy, particularly in younger patients.
Conclusions:
- Multivessel PCI improves cardiovascular outcomes in both diabetic and non-diabetic patients with multivessel CAD.
- Non-diabetic patients consistently achieve better outcomes following PCI compared to diabetic patients.
- Tailored revascularization strategies and further research are essential to optimize PCI outcomes for diabetic patients.
Objective:
To assess the outcomes of multivessel percutaneous coronary intervention (PCI) in diabetic and non-diabetic patients, focusing on improvements in angina grade, ejection fraction (EF), and dyspnoea.
Study Design:
An observational study. Place and Duration of the Study: Department of Cardiology, Kuwait Teaching Hospital, Peshawar, Pakistan, from January 2020 to December 2022.
Methodology:
A total of 500 patients, comprising 250 patients each with and without diabetes, all diagnosed with multivessel coronary artery disease and undergoing PCI, were included. Baseline and follow-up data were collected at 1-, 3-, 6-, and 12-month post-procedure. The primary outcomes assessed were the CCS angina grade, EF, and the NYHA dyspnoea classification. Statistical analyses included descriptive statistics, independent t-tests, chi-square tests, multivariate regression, and effect size calculations (Cohen's d).
Results:
Patients with diabetes showed more severe initial pathology, with higher angina grades (2.80 ± 0.59 vs. 2.38 ± 0.59, p <0.001) and lower EF (41.51 ± 7.89% vs. 44.2 ± 8.07%, p <0.001). Non-diabetic patients had better outcomes, with greater reduction in angina grades (1.23 ± 0.70 vs. 0.99 ± 0.71, p <0.001) and EF improvement (7.76 ± 4.58% vs. 6.55 ± 4.35%, p = 0.003). Dyspnoea reduction was similar between the groups (49.2% vs. 49.2%, p >0.99. Age-stratified analysis revealed the greatest diabetes-related EF deficit in younger patients (40-49 years: 8.1% difference), suggesting age-dependent cardiovascular effects. Multivariate regression showed that diabetes independently predicted reduced treatment efficacy.
Conclusion:
Multivessel PCI was associated with improvement in angina, EF, and dyspnoea class in diabetic and non-diabetic patients, with outcomes consistently better in non-diabetic patients. These findings highlight the need for tailored revascularisation strategies for diabetic patients. Further research is warranted to optimise PCI outcomes in this population.
Key Words:
Multivessel PCI, Angina, Ejection fraction, Dyspnoea, Diabetic, Non-diabetic, Coronary artery disease.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Diabetic Retinopathy
Diabetic Nephropathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Foot Ulcer
Complications of Diabetes Mellitus